Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
Rehabilitation Sciences Institute, Faculty of Medicine, University of Toronto, Toronto, Canada.
BMC Neurol. 2020 Jan 15;20(1):20. doi: 10.1186/s12883-019-1550-9.
Persons with spinal cord injury/dysfunction (SCI/D) often take multiple medications to treat their secondary complications and chronic conditions (multimorbidity). Multiple healthcare and service providers are often involved in care, which can result in increased risk of fragmentation of care. Optimal medication therapy management (MTM) is essential to ensure therapeutic benefit from medication regimens. However, little is known about the experiences of providers in supporting persons with SCI/D with MTM.
Telephone interviews were conducted to explore healthcare and service providers' experiences with MTM for persons with SCI/D. Participants were recruited through clinical organizations and researchers' personal contacts. Participants were purposefully selected for diversity in profession and were required to be English speaking and to have provided care to at least one person with SCI/D. The qualitative interviews followed a semi-structured interview guide. Data display matrices were used in a constant comparative process for descriptive and interpretive analysis.
Thirty-two interviews were conducted from April to December 2018. Each profession had distinct views on their roles in facilitating MTM for persons with SCI/D, which aligned with their respective scopes of practice. Shared provider tasks included tailoring medications, providing education, and exploring medication alternatives. Most participants felt that the care they provided for persons with SCI/D was similar to the care that they provided to other patients, with some differences relating to the physical limitations and medical complexity associated with SCI/D. Five factors were identified that impacted participants' abilities to provide MTM for persons with SCI/D: patient self-management skills, provider knowledge and confidence, provider-patient relationships, interprofessional collaboration, and provider funding models including the use of technology-supported consultations.
While participants described commonalities in the barriers and enablers associated with providing MTM to persons with SCI/D and other populations, there were unique considerations identified. These SCI/D-specific considerations resulted in recommendations for improvements in MTM for this population. Future research should include perspectives from persons with SCI/D.
脊髓损伤/功能障碍(SCI/D)患者常需服用多种药物来治疗其继发性并发症和慢性疾病(多种合并症)。通常有多位医疗保健和服务提供者参与患者的护理,这可能会导致护理碎片化风险增加。优化药物治疗管理(MTM)对于确保药物治疗方案的疗效至关重要。然而,对于提供者在支持 SCI/D 患者的 MTM 方面的经验,我们知之甚少。
通过电话访谈探讨医疗保健和服务提供者在 SCI/D 患者 MTM 方面的经验。参与者通过临床组织和研究人员的个人联系招募。根据专业的多样性,有目的地选择参与者,并要求他们会讲英语,且至少为一名 SCI/D 患者提供过护理。半结构化访谈指南指导定性访谈。使用数据展示矩阵进行描述性和解释性分析。
2018 年 4 月至 12 月进行了 32 次访谈。每个专业对促进 SCI/D 患者 MTM 的作用都有独特的看法,这与各自的实践范围一致。共同的提供者任务包括调整药物、提供教育和探索替代药物。大多数参与者认为他们为 SCI/D 患者提供的护理与他们为其他患者提供的护理相似,只是与 SCI/D 相关的身体限制和医疗复杂性存在一些差异。确定了五个影响参与者为 SCI/D 患者提供 MTM 的因素:患者自我管理技能、提供者知识和信心、医患关系、跨专业合作以及提供者的资金模式,包括使用技术支持的咨询。
尽管参与者描述了为 SCI/D 患者和其他人群提供 MTM 时的共同障碍和促进因素,但也确定了一些独特的考虑因素。这些与 SCI/D 相关的特定考虑因素导致了针对该人群 MTM 改进的建议。未来的研究应包括 SCI/D 患者的观点。